InvestorWire NewsRoom

InvestorNewsBreaks

NewsBreak Category: Tiny Gems
Wednesday Oct 12, 2022 - 2:59 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Partnering to Expedite Exports, Increase Global Market Penetration of Colombian Cannabis Goods

Flora Growth Corp. (NASDAQ: FLGC), a global cannabis brand builder, is increasing the strengths of its supply chain, centered in its 100-hectare (about 247-acre) cultivation facility located in the heart of Colombia’s green climate, by finalizing a three-year distribution agreement with the Misak indigenous tribe’s pharmaceutical arm. “Pharma Indigena Misak Manasr Sas, referred to simply as Manasr, is the tribe’s pharmaceutical enterprise, which in 2020…

Continue Reading

Wednesday Oct 12, 2022 - 11:45 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Announces Publication of Innovative Mathematical Model

Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced publication of a mathematical model for predicting the durability and rate of decay of neutralizing antibodies to SARS-CoV-2 in a peer-reviewed research paper in the Journal of Theoretical Biology. The publication, titled “A mathematical model of the within-host kinetics of SARS-CoV-2 neutralizing…

Continue Reading

Tuesday Oct 11, 2022 - 9:50 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), The Chopra Foundation Note World Mental Health Day

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), joined partner The Chopra Foundation in recognizing World Mental Health Day, which was Monday, Oct. 11, 2022. The two organizations are working together to research the potential of psychedelic-based therapies for the treatment of mental health and to provide education about the use of psychedelics. Founded by Dr. Deepak Chopra, The…

Continue Reading

Monday Oct 10, 2022 - 11:17 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Participate in Breakthrough for Brain Tumors(R) 5K Run

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run. The event is taking place on Saturday, Nov. 5, 2022, in Los Angeles, California. “The unmet…

Continue Reading

Friday Oct 07, 2022 - 2:39 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Rolling out Expansion Strategy to Capitalize on ‘Compelling Opportunities’

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, owns an extensive portfolio of proprietary technology that has made it a leader in B2B solutions. This is evidenced by the company’s record-breaking revenues and non-stop profitable quarters. “Backed by its stellar financial track record, GMGI is moving into the B2C social gaming sector. The company recently purchased an…

Continue Reading

Friday Oct 07, 2022 - 11:44 am

InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) AditxtScore(TM) Featured in FedEx Video Presentation

Aditxt (NASDAQ: ADTX), a biotech innovation company, has announced that its AditxtScore(TM) is featured by FedEx in a video presentation that showcases the various ways in which both companies are playing critical roles in a challenging environment that includes the nation’s response to COVID-19. In the clip, the Aditxt team provides a virtual tour of its AditxtScore(TM) Center and describes the company’s collaboration with scientists…

Continue Reading

Friday Oct 07, 2022 - 11:01 am

InvestorNewsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) Enter Merger Agreement for Acquisition

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, and MICT Inc. (NASDAQ: MICT), have signed a merger agreement outlining plans for MICT to acquire 100% of the operating business and assets of Tingo. According to the announcement, the new merger with the accompanying MICT funding should expedite the launch of Tingo’s food-produce export business; existing high-margin and material export contracts will allow a substantial portion…

Continue Reading

Friday Oct 07, 2022 - 10:55 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Advancement of Berubicin Clinical Trial Featured in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio release covers…

Continue Reading

Thursday Oct 06, 2022 - 2:32 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Elevating Performance with Expanded Team

Flora Growth Corp. (NASDAQ: FLGC), throughout 2022, has been implementing its hiring strategy that has seen the appointment of several key individuals whose proven talents and productivity are critical to the company’s goal of delivering the most compelling customer experiences. “Flora Growth ushered in the new year with the appointment of Tim Leslie as chairman of its newly formed advisory board. It would later bring…

Continue Reading

Thursday Oct 06, 2022 - 2:16 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Redefining Drug Delivery Platforms

Lexaria Bioscience Corp. (NASDAQ: LEXX) has remained committed to improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream. “Moreover, as a global innovator in drug delivery platforms, the company has not shied away from advancing its research to cut across various health conditions, including but not limited to hypertension, epilepsy, diabetes, and dementia, among others. These efforts have yielded 27 granted patents around the…

Continue Reading

Thursday Oct 06, 2022 - 10:38 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) ‘Focused on Adding Targeted IP’

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today provided an update on its intellectual property (“IP”) progress in support of its research and development strategy. According to the update, Cybin continues to prioritize the development of in-house IP and licensing opportunities that support its active development programs and future novel drug candidates. The company has more than…

Continue Reading

Wednesday Oct 05, 2022 - 11:42 am

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Ideally Poised as Growing Consensus Points to Lidar as Essential Solution

Cepton (NASDAQ: CPTN), a developer of lidar-based solutions that help enable Advanced Driver Assistance Systems (“ADAS”), autonomous vehicles (“AVs”), smart cities, connected spaces, and smart industrial applications, is ideally poised as expert opinions concerning AV safety lean in favor of using lidar technologies in addition to HD cameras. “The safety of AVs and ADAS hinges on the ability of vehicle’s systems to sense surrounding objects.…

Continue Reading

Tuesday Oct 04, 2022 - 12:00 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Positioned for Continued Growth Amid Prevailing Market Trends

Freight Technologies (NASDAQ: FRGT), a company that simplifies cross-border shipping and daily carrier operations through its B2B marketplace Fr8App, recently filed a Form F-1 with the Securities and Exchange Commission (“SEC”). “In the recently filed Form F-1, Fr8Tech, a British Virgin Islands-incorporated technology company developing supply chain optimization and automation solutions and providing its Fr8App platform for B2B cross-border shipping, registered more than 19 million…

Continue Reading

Monday Oct 03, 2022 - 12:57 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Poised to Bring ‘Potentially Impactful’ Therapy to GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP), a preclinical stage biotechnology company specializing in developing novel treatments for brain tumors, has focused on its lead drug candidate, Berubicin, to potentially treat glioblastoma (“GBM”). “CNS has since made significant headway, even receiving FDA Fast Track Designation, which now offers it an accelerated path to approval for Berubicin. ‘With this designation, we now have an accelerated pathway to approval for…

Continue Reading

Friday Sep 30, 2022 - 2:41 pm

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Working to Make a Difference in Underserved Patient Populations

QSAM Biosciences (OTCQB: QSAM) is a clinical-stage biotechnology company focused on developing and bringing to market targeted therapeutic radiopharmaceuticals and advancing the fight against cancer, including the underserved pediatric population. “With the overall incidence of childhood cancer on the rise, the work of QSAM is becoming increasingly important… According to Children’s Cancer Cause, in 2022, an estimated 10,470 children (from birth to 14 years) and…

Continue Reading

Friday Sep 30, 2022 - 1:31 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Expand Indications, Efficacy of DehydraTECH(TM)

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently received its 27th worldwide patent, granted in Mexico under registration #390001. “The patent applies to a range of active ingredients, including but not limited to non-psychoactive cannabinoids and NSAIDs in a wide variety of ready-to-drink consumer retail beverage products. The latest patent provides value to the company through its continued pursuit of…

Continue Reading

Friday Sep 30, 2022 - 12:00 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Engages IBN for Corporate Communications Expertise

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), which develops solutions to optimize and automate the supply chain process, today announced that it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. As part of the client partner relationship, IBN will work to generate greater awareness for Freight Technologies by leveraging its investor based distribution network of…

Continue Reading

Thursday Sep 29, 2022 - 3:27 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Show to Take the Spotlight in Huntley, Illinois

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land in the suburbs of Chicago at Huntley Village Green, in Huntley, Illinois, on Oct. 3, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling…

Continue Reading

Thursday Sep 29, 2022 - 12:21 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system. The company today announced its receipt of confirmation from the Nasdaq Stock Market LLC Hearing Panel that it has regained compliance with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2). In addition, Nasdaq confirmed that Aditxt meets…

Continue Reading

Wednesday Sep 28, 2022 - 1:13 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Activates First European Sites for Potentially Pivotal Clinical Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of…

Continue Reading

Wednesday Sep 28, 2022 - 12:46 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Roadshow Makes Ohio Stop

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, is slated for a visit in New Albany, Ohio, on Sept. 29, 2022. The company’s Robot Roadshow is a creative event designed to provide hands-on experiences for those interested in its Autonomous Security Robots (“ASRs”). The unique event is an engaging experiential event for potential clients that grabs attention,…

Continue Reading

Wednesday Sep 28, 2022 - 10:01 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Releases New Info about Upcoming Mullen Five RS

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced an upcoming version of its Mullen Five crossover that delivers a performance “to rival Plaid versions of Tesla’s Model S and Model X.” The Mullen Five was originally meant to compete against Tesla’s Model Y and Volkswagen ID.4, but the new version features more than 1,000 horsepower and the ability to go from 0…

Continue Reading

Monday Sep 26, 2022 - 3:20 pm

InvestorNewsBreaks – Cepton Inc.’s (NASDAQ: CPTN) Short-Range Lidar Solution Aims to Bring Safety Benefits to Everyone on the Road

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of lidar-based solutions for autonomous vehicles (“AV”), advanced driver assistance systems (“ADAS”) and smart technology spaces, is leading the way with Nova, an award-winning short-range lidar solution that’s lightweight, flexible, energy-efficient, and easy to integrate into passenger and commercial vehicles. “CPTN recently announced the company’s collaboration with ZKW Group GmbH to demonstrate Nova at the IAA Transportation Conference……

Continue Reading

Wednesday Sep 21, 2022 - 2:31 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Collaborates to Bridge Concept-to-Deployment Gap in Autonomous Driving Technology

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has announced its collaboration with NVIDIA to add Cepton lidar models into NVIDIA DRIVE Sim(TM). According to the update, DRIVE Sim is an end-to-end simulation platform that enables large-scale, physically based multi-sensor simulation to support the development and validation of autonomous driving. “Lidar is essential to autonomous mobility, but deploying lidar at…

Continue Reading

Wednesday Sep 21, 2022 - 12:49 pm

InvestorNewsBreaks — Mullen Automotive Inc.’s (NASDAQ: MULN) Bollinger Motors Teams Up with Wabash to Develop New Body on Electric Chassis

Mullen Automotive (NASDAQ: MULN), through its recent majority acquisition, Bollinger Motors Inc., is partnering with Wabash, a leading truck body and trailer manufacturer. The partnership will focus on developing a stronger, lighter, refrigerated truck body on an electric chassis. The plan is to seamlessly integrate Bollinger’s Class 4 electric chassis cab with Wabash’s lightweight composite technology, EcoNex(TM), which will be used in truck bodies and…

Continue Reading

Wednesday Sep 21, 2022 - 11:01 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences

Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(TM). The company today announced its participation in upcoming conferences taking place in September and October 2022. The company’s CEO Doug Drysdale participated in a panel discussion titled “Trials to Treatments” at the Interdisciplinary Conference on Psychedelic Research, Psychedelic Science, Ethics & Business Event in Haarlem, Amsterdam. The announcement includes…

Continue Reading

Wednesday Sep 21, 2022 - 9:57 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on Recently Announced $20M Public Offering

Aditxt Inc. (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, has closed on its recent public offering. The offering was comprised of 3,333,333 shares of common stock or common stock equivalents; the offering also included warrants to purchase up to 3,333,333 shares of common stock. The combined offering price to the public was $6 per share…

Continue Reading

Wednesday Sep 21, 2022 - 9:43 am

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) to Take the Spotlight with a Robot Show in Sterling, Virginia

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land at 22895 Ladbrook Drive in Sterling, Virginia, on Sept. 20-21, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The…

Continue Reading

Tuesday Sep 20, 2022 - 2:19 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Hypertension Drug Market with Proprietary Drug-Delivery Method

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is focused on establishing a stronghold in the $28 billion hypertension drug market. The company’s exclusive therapeutic, DehydraTECH-CBD, has shown exciting potential as an alternative to traditional cannabidiol (“CBD”) dosing methods; the proprietary treatment may offer improved and more rapid absorption of drugs into the bloodstream and brain. According to the announcement, only one FDA-approved…

Continue Reading

Tuesday Sep 20, 2022 - 1:35 pm

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces R&B Milestones, Beats Anticipated Timeframe

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has successfully reached key research and development (“R&D”) milestones that were identified in the company’s acquisition agreement of Adelia Therapeutics in 2020. The milestones were reached faster than expected, and have helped Cybin make progress on its path toward clinical drug development. The milestones were key in moving Cybin’s psychedelic programs…

Continue Reading

Tuesday Sep 20, 2022 - 10:14 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Release FY 2022 Financial Report, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, will be releasing its financial report for fiscal year 2022, the period ended June 30, 2022, later this month. The company has announced that it will release the financial report, along with business highlights, on Sept. 23, 2022. In addition, the company has announced a conference call and webcast to…

Continue Reading

Friday Sep 16, 2022 - 1:46 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Leading Charge to Find Potential Treatment Option for GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a preclinical stage biotechnology company, is looking to fill a gap in the treatment of Glioblastoma Multiforme (“GBM”), an aggressive form of cancer that occurs in the brain or spinal cord, with its lead product candidate Berubicin. “GBM is considered one of the most complex, deadly and treatment-resistant cancers. And although it is regarded as rare, between 12,000 and 15,000 Americans…

Continue Reading

Friday Sep 16, 2022 - 1:27 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Leading Way in Scaling up Lidar for Mass-Market Deployments

Cepton (NASDAQ: CPTN) has, since its inception, sought to market the concept of “Lidar for Life,” introducing the use of lidar technology in mass-market consumer vehicles as well as the development of smart infrastructure in cities, spaces and industrial robotics. “As a pivotal part of its efforts in promoting lidar technology across different sectors, the company has invested in making lidar a truly scalable and…

Continue Reading

Thursday Sep 15, 2022 - 2:16 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures Expanded Contract with Oregon-Based Client

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that a locally owned, Oregon-based healthcare system has expanded its contract for its many facilities in the state. The announcement reads, “On the heels of securing a contract for a Knightscope K5 Autonomous Security Robot (‘ASR’), the new client has increased its order for an additional 2…

Continue Reading

Thursday Sep 15, 2022 - 1:35 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Hypertension Treatment Program Stands Distinct

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. The information includes a discussion of underlying logic-based evaluations that offer a realistic framework of expectations that investors can use in their analysis. “One of the logic-based evaluations considers the stage at which a…

Continue Reading

Thursday Sep 15, 2022 - 12:22 pm

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Provides First Look at Its Ultra-High-Performance FIVE RS

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced specifications and unveiled details on the FIVE RS - its ultra-high-performance EV sport crossover. The Mullen FIVE RS will be equipped with 800-volt architecture, all-wheel drive, a two-speed gearbox and over 1,000 horsepower and feature a top speed of 200 mph and acceleration from 0-60 mph in just 1.9 seconds. “From the inception…

Continue Reading

Thursday Sep 15, 2022 - 10:45 am

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Participation in H.C. Wainwright Global Investment Conference

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for business-to-business (“B2B”) cross-border shipping in the United States/Mexico/Canada (“USMC”) region, will be presenting today at the H.C. Wainwright 24th Annual Global Investment Conference. Scheduled for Sept. 12–14, the three-day conference has been held in New York City as a hybrid event;…

Continue Reading

Wednesday Sep 14, 2022 - 12:36 pm

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marking Industry’s First-Ever Entry of Novel Psilocybin Analog into Clinical Development

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is making significant headway with its flagship deuterated psilocybin analog, CYB003. “CYB003 has the potential to effectively treat alcohol use disorder (‘AUD’) and major depressive disorder (‘MDD’). The substance is designed to achieve less variability in plasma levels, faster onset of action, shorter…

Continue Reading

Wednesday Sep 14, 2022 - 9:53 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $6M Private Placement Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has closed on a private placement agreement with two healthcare-focused institutional investors. The agreement consisted of the issue and sale of 691,245 of INM common shares prices at $8.68 per share (or prefunded warrant in lieu thereof), totaling approximately $6 million. According to the announcement, INM also issued unregistered preferred…

Continue Reading

Monday Sep 12, 2022 - 10:00 am

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Acquisition of Controlling Stake in Bollinger Motors Featured in Recent Articles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in recent articles published by InsideEVs and Newsweek that discussed its strategic move to purchase a controlling stake in Bollinger Motors. “EV fresh face Mullen Automotive has purchased a 60% controlling stake in Bollinger Motors for $148.2 million USD cash. It’s the company’s first EV acquisition after having purchased many of its building…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).